Ethnic differences in polyomavirus simian virus 40 seroprevalence among women in Houston, Texas

Journal of Infection

Volumn 66, Issue 1, 2013, Pages 67-74

  Wong, Connie ^a   Vilchez, Regis A ^a   Quiroz, Jorge ^b   Adam, Ervin ^a   Butel, Janet S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Polyomavirus SV40; Simian virus 40; SV40 seroprevalence

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; POLYOMAVIRUS INFECTION; PREGNANT WOMAN; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE; SIMIAN VIRUS 40; UNITED STATES; VIRUS NEUTRALIZATION;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; ANTIBODIES, VIRAL; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; SEROEPIDEMIOLOGIC STUDIES; SIMIAN VIRUS 40; TEXAS;

EID: 84870755848     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.08.014     Document Type: Article

References (61)

1. King A.M.Q., Adams M.J., Carstens E.B., Lefkowitz E.J. Virus taxonomy 2012, Ninth Report of the International Committee on Taxonomy of Viruses, Academic Press, San Diego.
2. Virology division, international union of microbiological societies 2012, International Committee on Taxonomy of Viruses. http://www.ictvonline.org.
3. Shah K., Nathanson N. Human exposure to SV40: review and comment. Am J Epidemiol 1976, 103:1-12.
4. Butel J.S. Polyomavirus SV40: model infectious agent of cancer. Cancer associated viruses 2012, 377-417. Springer Science. E. Robertson (Ed.).
5. Butel J.S. Patterns of polyomavirus SV40 infections and associated cancers in humans: a model. Curr Opin Virol 2012, 2:508-514.
6. Stratton K., Almario D.A., McCormick M.C. Immunization safety review: SV40 contamination of polio vaccine and cancer 2003, The National Academies Press, Washington, DC.
7. Vilchez R.A., Butel J.S. Emergent human pathogen simian virus 40 and its role in cancer. Clin Microbiol Rev 2004, 17:495-508.
8. Vilchez R.A., Kozinetz C.A., Butel J.S. Conventional epidemiology and the link between SV40 and human cancers. Lancet Oncol 2003, 4:188-191.
9. Fraumeni J.F., Ederer F., Miller R.W. An evaluation of the carcinogenicity of simian virus 40 in man. J Am Med Assoc 1963, 185:85-90.
10. Pan American Sanitary Bureau. First International Conference on Live Poliovirus Vaccines (Washington, D.C., 22-26 June 1959). Papers Presented and Discussions Held. Washington, D.C.: Pan American Sanitary Bureau, Scientific Publication No. 44; 1959.
11. Pan American Sanitary Bureau. Second International Conference on Live Poliovirus Vaccines (Washington, D.C., 6-10 June 1960). Papers Presented and Discussions Held. Washington, D.C.: Pan American Sanitary Bureau, Scientific Publication No. 50; 1960.
12. Butel J.S. Simian virus 40, human infections, and cancer: emerging concepts and causality considerations. Viral oncology: basic science and clinical applications 2010, 165-189. Wiley-Blackwell, Hoboken, NJ. K. Khalili, K.T. Jeang (Eds.).
13. Nurgalieva Z.Z., Wong C., Zhangabylov A.K., Omarbekova Z.E., Graham D.Y., Vilchez R.A., et al. Polyomavirus SV40 infections in Kazakhstan. J Infect 2005, 50:142-148.
14. Butel J.S., Wong C., Vilchez R.A., Szücs G., Dömök I., Kriz B., et al. Detection of antibodies to polyomavirus SV40 in two central European countries. Cent Eur J Public Health 2003, 11:3-8.
15. Minor P., Pipkin P., Jarzebek Z., Knowles W. Studies of neutralising antibodies to SV40 in human sera. J Med Virol 2003, 70:490-495.
16. Meneses A., Lopez-Terrada D., Zanwar P., Killen D.E., Monterroso V., Butel J.S., et al. Lymphoproliferative disorders in Costa Rica and simian virus 40. Haematologica 2005, 90:1635-1642.
17. Viscidi R.P., Rollison D.E.M., Viscidi E., Clayman B., Rubalcaba E., Daniel R., et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol 2003, 10:278-285.
18. Shah K.V., Galloway D.A., Knowles W.A., Viscidi R.P. Simian virus 40 (SV40) and human cancer: a review of the serological data. Rev Med Virol 2004, 14:231-239.
19. Kean J.M., Rao S., Wang M., Garcea R.L. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009, 5:e1000363.
20. Butel J.S., Jafar S., Wong C., Arrington A.S., Opekun A.R., Finegold M.J., et al. Evidence of SV40 infections in hospitalized children. Hum Pathol 1999, 30:1496-1502.
21. Rollison D.E.M., Helzlsouer K.J., Alberg A.J., Hoffman S., Hou J., Daniel R., et al. Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors. Cancer Epidemiol Biomark Prev 2003, 12:460-463.
22. Jafar S., Rodriguez-Barradas M., Graham D.Y., Butel J.S. Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J Med Virol 1998, 54:276-284.
23. Corallini A., Mazzoni E., Taronna A., Manfrini M., Carandina G., Guerra G., et al. Specific antibodies reacting with simian virus 40 capsid protein mimotopes in serum samples from healthy blood donors. Hum Immunol 2012, 73:502-510.
24. Khalili K., Stoner G.L. Preface. Human polyomaviruses: molecular and clinical perspectives 2001, xi-xii. Wiley-Liss, Inc., New York. K. Khalili, G.L. Stoner (Eds.).
25. Hsiung G.D., Fong C.K.Y., Landry M.L. Hsiung's diagnostic virology 1994, Yale University Press, New Haven. 4th ed.
26. Vanchiere J.A., Nicome R.K., Greer J.M., Demmler G.J., Butel J.S. Frequent detection of polyomaviruses in stool samples from hospitalized children. J Infect Dis 2005, 192:658-664.
27. Wong A.S.Y., Cheng V.C.C., Yuen K.-Y., Kwong Y.-L., Leung A.Y.H. High frequency of polyoma BK virus shedding in the gastrointestinal tract after hematopoietic stem cell transplantation: a prospective and quantitative analysis. Bone Marrow Transplant 2009, 43:43-47.
28. Vanchiere J.A., Abudayyeh S., Copeland C.M., Lu L.B., Graham D.Y., Butel J.S. Polyomavirus shedding in the stool of healthy adults. J Clin Microbiol 2009, 47:2388-2391.
29. Bialasiewicz S., Whiley D.M., Lambert S.B., Nissen M.D., Sloots T.P. Detection of BK, JC, WU, or KI polyomaviruses in faecal, urine, blood, cerebrospinal fluid and respiratory samples. J Clin Virol 2009, 45:249-254.
30. Babakir-Mina M., Ciccozzi M., Alteri C., Polchi P., Picardi A., Greco F., et al. Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders. J Med Virol 2009, 81:1668-1673.
31. Bofill-Mas S., Formiga-Cruz M., Clemente-Casares P., Calafell F., Girones R. Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol 2001, 75:10290-10299.
32. McQuaig S.M., Scott T.M., Harwood V.J., Farrah S.R., Lukasik J.O. Detection of human-derived fecal pollution in environmental waters by use of a PCR-based human polyomavirus assay. Appl Environ Microbiol 2006, 72:7567-7574.
33. Bofill-Mas S., Rodriguez-Manzano J., Calgua B., Carratala A., Girones R. Newly described human polyomaviruses Merkel cell, KI and WU are present in urban sewage and may represent potential environmental contaminants. Virol J 2010, 7:e141.
34. Melnick J.L., Stinebaugh S. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc Soc Exp Biol Med 1962, 109:965-968.
35. Patel N.C., Halvorson S.J., Sroller V., Arrington A.S., Wong C., Smith E.O., et al. Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters. Virology 2009, 386:94-101.
36. Martini F., Iaccheri L., Lazzarin L., Carinci P., Corallini A., Gerosa M., et al. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res 1996, 56:4820-4825.
37. Yamamoto H., Nakayama T., Murakami H., Hosaka T., Nakamata T., Tsuboyama T., et al. High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients. Br J Cancer 2000, 82:1677-1681.
38. David H., Mendoza S., Konishi T., Miller C.W. Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett 2001, 162:57-64.
39. Li R.M., Branton M.H., Tanawattanacharoen S., Falk R.A., Jennette J.C., Kopp J.B. Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol 2002, 13:2320-2330.
40. Martini F., Lazzarin L., Iaccheri L., Vignocchi B., Finocchiaro G., Magnani I., et al. Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors. Cancer 2002, 94:1037-1048.
41. Nakatsuka S.-I., Liu A., Dong Z., Nomura S., Takakuwa T., Miyazato H., et al. Simian virus 40 sequences in malignant lymphomas in Japan. Cancer Res 2003, 63:7606-7608.
42. Paracchini V., Garte S., Pedotti P., Poli F., Frison S., Taioli E. Molecular identification of simian virus 40 infection in healthy Italian subjects by birth cohort. Mol Med 2005, 11:48-51.
43. Zekri A.N., Bahnassy A.A., Mohamed W.S., Hassan N., Abdel-Rahman A.M., El-Kassem F.A., et al. Evaluation of simian virus-40 as a biological prognostic factor in Egyptian patients with malignant pleural mesothelioma. Pathol Int 2007, 57:493-501.
44. Heinsohn S., Szendroi M., Bielack S., zur Stadt U., Kabisch H. Evaluation of SV40 in osteosarcoma and healthy population: a Hungarian-German study. Oncol Rep 2009, 21:289-297.
45. Lapin B.A., Chikobava M.G. Detection of SV40 in blood samples from healthy subjects in the Russian federation by RT-PCR. Vestn Ross Akad Med Nauk 2009, (4):7-10. [Article in Russian].
46. Pancaldi C., Balatti V., Guaschino R., Vaniglia F., Corallini A., Martini F., et al. Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution. J Infect 2009, 58:53-60.
47. Adam E., Kaufman R.H., Melnick J.L., Levy A.H., Rawls W.E. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. III. Houston, Texas. Am J Epidemiol 1973, 96:427-442.
48. LaBarthe D., Adam E., Noller K.L., O'Brien P.C., Robboy S.J., Tilley B.C., et al. Design and preliminary observations of national cooperative diethylstilbestrol adenosis (DESAD) project. Obstet Gynecol 1978, 51:453-458.
49. Hoover R.N., Hyer M., Pfeiffer R.M., Adam E., Bond B., Cheville A.L., et al. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 2011, 365:1304-1314.
50. Kaufman R.H., Adam E., Icenogle J., Lawson H., Lee N., Reeves K.O., et al. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1997, 176:87-92.
51. Houston T.X. 2010 census profile 2012, http://www.usatoday.com/news/nation/census/profile/TX.
52. Shah K.V. SV40 and human cancer: a review of recent data. Int J Cancer 2006, 120:215-223.
53. Ramos Alvarez M., Gómez Santos F., Rangel Rivera L., Mayes O. Viral and serological studies in children immunized with live poliovirus vaccine-preliminary report of a large trial conducted in Mexico 1959, First International Conference on Live Poliovirus Vaccines. Papers presented and Discussions Held, Pan American Sanitary Bureau, Washington, DC, Scientific Publication No. 44, p. 483-496.
54. Guevara Rojas A. Poliomyelitis vaccination with Sabin oral vaccine in Mexico City and six precincts of the Federal District 1959, First International Conference on Live Poliovirus Vaccines. Papers Presented and Discussions Held, Pan American Sanitary Bureau, Washington, DC, Scientific Publication No. 44, p. 622-637.
55. Ramos Alvarez M., Bustamante M.E., Alvarez Alba R. Use of Sabin's live poliovirus vaccine in Mexico. Results of a large-scale trial 1960, Second International Conference on Live Poliovirus Vaccines. Papers Presented and Discussions Held, Pan American Health Organization, Washington, DC, Scientific Publication No. 50, p. 386-412.
56. Núñez J., Vargas-Méndez O., Guevara E.C., Quirce J.M., Montoya J.A., Doany H., et al. Vaccination with attenuated polioviruses in Costa Rica. Second progress report. Section I. Vaccination program 1960, Second International Conference on Live Poliovirus Vaccines. Papers Presented and Discussions Held, Pan American Health Organization, Washington, DC, Scientific Publication No. 50, p. 561-568.
57. Alcocer J.J., Armijo R., da Silva M.M. Vaccination and challenge-poliomyelitis in Nicaragua, 1959-1960 1960, Second International Conference on Live Poliovirus Vaccines. Papers Presented and Discussions Held, Pan American Health Organization, Washington, DC, Scientific Publication No. 50, p. 547-560.
58. Vieira de Campos A.L. A história da poliomielite no Brasil e seu controle por imunização. História, Ciências, Saúde - Manguinhos 2003, 10(Suppl. 2):573-600.
59. Toracchio S., Kozinetz C.A., Killen D.E., Sheehan A.M., Banez E.I., Ittmann M.M., et al. Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX. J Clin Virol 2009, 46:154-160.
60. Vilchez R.A., Lopez-Terrada D., Middleton J.R., Finch C.J., Killen D.E., Zanwar P., et al. Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS-related non-Hodgkin's lymphoma. Virology 2005, 342:38-46.
61. Haile R.W., John E.M., Levine A.J., Cortessis V.K., Unger J.B., Gonzales M., et al. A review of cancer in U.S. Hispanic populations. Cancer Prev Res 2012, 5:150-163.